Form 4: HealthStream Director Converts Restricted Stock Units into Common Shares

HealthStream Inc. Director Amir Alex Jahangir converted 2,132 restricted share units into common stock on June 9, 2025, increasing his direct beneficial ownership to 3,257 shares.

Summary

• Amir Alex Jahangir, a Director of HealthStream Inc. (HSTM), reported a change in beneficial ownership on June 9, 2025.
• He acquired 2,132 shares of common stock through the vesting and conversion of restricted share units (RSUs) at a price of $0 per share.
• Following this transaction, Mr. Jahangir directly beneficially owns a total of 3,257 shares of HealthStream common stock.
• The converted RSUs were part of two separate grants, both subject to three-year vesting schedules contingent upon continued service.
• One batch of RSUs, from which 1,126 units were converted, began vesting annually on June 6, 2024, in three equal installments, with 1,126 units remaining unvested.
• Another batch of RSUs, from which 1,006 units were converted, began vesting annually on May 30, 2025, in three equal installments, with 2,012 units remaining unvested.

Sentiment

Score: 7

Explanation: The transaction reflects the routine vesting of equity compensation, which is a pre-scheduled and expected event. The increase in direct ownership by a director, even if not a discretionary purchase, is generally viewed as a positive signal of alignment with shareholder interests.

Positives

• Director Amir Alex Jahangir increased his direct ownership of HealthStream common stock by 2,132 shares, which can be viewed as a positive signal of confidence in the company's future.
• The acquisition of shares resulted from the vesting of restricted share units, indicating the fulfillment of service-based conditions and a routine part of executive compensation.

Future Outlook

This Form 4 filing is a report of a past insider transaction and does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing is a routine insider transaction report, specifically detailing the vesting and conversion of equity compensation for a director. It does not provide broader industry context or trends, but reflects standard practices for executive and director compensation within publicly traded companies.

Comparison to Industry Standards

• The vesting of restricted share units is a common form of equity compensation across various industries, aligning executive and director incentives with long-term shareholder value.
• The specific size of the grant and the resulting ownership stake would typically be compared to compensation practices of directors at peer companies within the healthcare technology or software industry, though such comparative data is not provided in this filing.

Stakeholder Impact

• Shareholders: The director's increased direct ownership aligns his financial interests more closely with those of the company's shareholders.
• Employees: The vesting of RSUs is a common form of equity compensation for executives and directors, reflecting standard corporate compensation practices.

Next Steps

• Future vesting events for the remaining 3,138 restricted share units will occur as per their respective schedules, with annual installments continuing from June 6, 2024, and May 30, 2025.

Key Dates

Keywords

HealthStream, HSTM, SEC Form 4, Insider Transaction, Restricted Share Units, RSU, Stock Ownership, Director Compensation, Equity Compensation